Whalegun
Home

Astrazeneca AZN paid Tarplin, Downs & Young $80K for lobbying in Q3 2023 · Budget, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q3 2023
Stock
Astrazeneca AZN
Client
Astrazeneca
Reported
23/10/17

Up 0.0% from last quarter

What else happened in Astrazeneca around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Astrazeneca's other lobbying reports

  • Astrazeneca

    LobbyingAstrazeneca

    $80K

    Reported 07/19

  • Astrazeneca

    LobbyingAstrazeneca

    $80K

    Reported 07/16

  • Astrazeneca

    LobbyingAstrazeneca

    $80K

    Reported 04/20

  • Astrazeneca

    LobbyingAstrazeneca

    $80K

    Reported 04/18

  • Astrazeneca

    LobbyingAstrazeneca

    $80K

    Reported 01/20

Astrazeneca AZN paid Tarplin, Downs & Young $80K for lobbying in Q3 2023 · Budget, Medicare and 1 more issue | Whalegun